Management of Cancer-Associated Venous Thromboembolism in the Emergency Department.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28169053.
- Also identified by DOI 10.1016/j.annemergmed.2016.12.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.
Medical subject headings
- Anticoagulants
- Emergency Service, Hospital
- Heparin, Low-Molecular-Weight
- Neoplasms
- Practice Guidelines as Topic
- Venous Thromboembolism
- Vitamin K